His parents have now filed a lawsuit against both the pharmacy benefits-management company and Walgreens, claiming they are responsible for their son's death. The Schmidtknechts' ...

The family of Cole Schmidtknecht accuse OptumRx and Walgreens of having a part in their son’s death. As we reported last month, the 22-year-old didn’t have an asthma inhaler when he suffered a ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

In the lawsuit complaint, Cole's parents, Bil and Shanon Schmidtknecht, allege both OptumRx and Walgreens were negligent and bear responsibility for their son's death. Five days before Cole's ...

Cole Schmidtknecht expected to pay $66.86 for a three-month supply of his preventative asthma inhalers in January 2024 when he went to his Walgreens pharmacy in Appleton, Wisconsin. The pharmacy ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

APPLETON, Wis. — A Wisconsin couple filed a federal lawsuit against both Walgreens and OptumRx, a subsidiary of UnitedHealth Group, claiming their son died due to a sudden $500 spike in his ...

The three largest pharmacy benefit managers are looking to take their legal back-and-forth with the Federal Trade Commission to the 8th Circuit Court, according to a court filing issued late last week ...

In a court filing Tuesday, U.S. District Judge Matthew Schelp denied a request by CVS Health’s CVS Caremark, Cigna’s Express Scripts and UnitedHealth Group’s OptumRx for a preliminary ...

The family of Cole Schmidtknecht accuse OptumRx and Walgreens of having a part in their son’s death. As we reported last month, the 22-year-old didn’t have an asthma inhaler when he suffered a ...